Jan. 4, 2007 — Apogee Technology Inc., a Norwood, Mass. -based micro-systems and nanotechnology company that designs, develops and commercializes medical devices and sensor products, announced that it has completed the installation of a dedicated laboratory facility at its headquarters to support the research and development efforts associated with its medical products group.

This new capability and planned expansion in staff will be used to further develop Apogee’s PyraDerm drug delivery system and enhance its pursuit of polymer drug formulations that can be applied to its transdermal delivery systems.

“Our initial laboratory efforts will be directed toward developing advanced drug delivery formulations and supporting our proof of concept studies in vivo, or in living systems,” said Alexander Andrianov, Apogee’s vice president of research and development, in a prepared statement. “With our new laboratory facility we will have the capability to perform formulation studies, produce samples for preliminary in vitro and in vivo testing, and provide real-time analytical and quality control support for our research efforts. By bringing this capability in-house we believe that we will significantly improve our control over the time and cost to perform our research and development activities, as well as better protect our intellectual property developments.”